| Literature DB >> 35966449 |
Mehdi A Kamran1,2, Reza Kia3, Fariba Goodarzian4, Peiman Ghasemi5.
Abstract
With the discovery of the COVID-19 vaccine, what has always been worrying the decision-makers is related to the distribution management, the vaccination centers' location, and the inventory control of all types of vaccines. As the COVID-19 vaccine is highly demanded, planning for its fair distribution is a must. University is one of the most densely populated areas in a city, so it is critical to vaccinate university students so that the spread of this virus is curbed. As a result, in the present study, a new stochastic multi-objective, multi-period, and multi-commodity simulation-optimization model has been developed for the COVID-19 vaccine's production, distribution, location, allocation, and inventory control decisions. In this study, the proposed supply chain network includes four echelons of manufacturers, hospitals, vaccination centers, and volunteer vaccine students. Vaccine manufacturers send the vaccines to the vaccination centers and hospitals after production. The students with a history of special diseases such as heart disease, corticosteroids, blood clots, etc. are vaccinated in hospitals because of accessing more medical care, and the rest of the students are vaccinated in the vaccination centers. Then, a system dynamic structure of the prevalence of COVID -19 in universities is developed and the vaccine demand is estimated using simulation, in which the demand enters the mathematical model as a given stochastic parameter. Thus, the model pursues some goals, namely, to minimize supply chain costs, maximize student desirability for vaccination, and maximize justice in vaccine distribution. To solve the proposed model, Variable Neighborhood Search (VNS) and Whale Optimization Algorithm (WOA) algorithms are used. In terms of novelties, the most important novelties in the simulation model are considering the virtual education and exerted quarantine effect on estimating the number of the vaccines. In terms of the mathematical model, one of the remarkable contributions is paying attention to social distancing while receiving the injection and the possibility of the injection during working and non-working hours, and regarding the novelties in the solution methodology, a new heuristic method based on a meta-heuristic algorithm called Modified WOA with VNS (MVWOA) is developed. In terms of the performance metrics and the CPU time, the MOWOA is discovered with a superior performance than other given algorithms. Moreover, regarding the data, a case study related to the COVID-19 pandemic period in Tehran/Iran is provided to validate the proposed algorithm. The outcomes indicate that with the demand increase, the costs increase sharply while the vaccination desirability for students decreases with a slight slope.Entities:
Keywords: Artificial intelligence algorithm; Desirability for the vaccination; Distribution-location-allocation; Distributive justice; Simulation model; Stochastic optimization; Vaccine supply chain
Year: 2022 PMID: 35966449 PMCID: PMC9359548 DOI: 10.1016/j.seps.2022.101378
Source DB: PubMed Journal: Socioecon Plann Sci ISSN: 0038-0121 Impact factor: 4.641
Vaccination trend in 11 countries (2.14.2022).
| Region | COVID-19 vaccination % to total population | Total doses |
|---|---|---|
| China | 85.05 | 3,036,707,000 |
| USA | 64.25 | 547,154,250 |
| India | 54.51 | 1,729,559,610 |
| Brazil | 71.30 | 337,626,315 |
| UK | 71.51 | 138,942,048 |
| Germany | 74.21 | 167,885,429 |
| France | 77.19 | 139,804,600 |
| Italy | 77.87 | 132,064,916 |
| Turkey | 61.92 | 144,007,120 |
| Mexico | 60.26 | 172,480,864 |
Fig. 1Configuration of the considered COVID-19 vaccine supply chain network.
Fig. 2Research framework.
Fig. 3Interaction structure of COVID-19 prevalence in universities.
Fig. 4VNS pseudo-code [43].
Fig. 5The neighborhood structures.
Fig. 6WOA pseudo-code [46].
Fig. 7MVWOA pseudo-code.
Numerical experiment of problems in different sizes.
| Classification | Example | ||||||
|---|---|---|---|---|---|---|---|
| Small | S1 | 2 | 1 | 1 | 2 | 1 | 1 |
| S2 | 3 | 1 | 1 | 3 | 1 | 1 | |
| S3 | 4 | 1 | 2 | 4 | 1 | 1 | |
| S4 | 4 | 2 | 2 | 5 | 1 | 2 | |
| S5 | 5 | 2 | 2 | 6 | 1 | 2 | |
| Medium | M1 | 8 | 3 | 3 | 8 | 2 | 3 |
| M2 | 10 | 3 | 3 | 14 | 2 | 4 | |
| M3 | 12 | 4 | 4 | 18 | 2 | 4 | |
| M4 | 14 | 4 | 5 | 24 | 2 | 5 | |
| M5 | 18 | 6 | 5 | 28 | 2 | 6 |
Presented parameters ( =uniform).
| Parameter | Value | Parameter | Value |
|---|---|---|---|
| 1,000,000,000,000 | |||
Presented levels and factors for the proposed algorithms.
| Algorithm | Factor | Level |
|---|---|---|
| 1 2 3 | ||
| A. Maximum iteration ( | A1:500 A2:1500 A3: 2000 | |
| A. Maximum iteration ( | A1:500 A2:1500 A3:2000 |
Orthogonal array L9 for WOA and MVWOA.
| L9 | A | B | C |
|---|---|---|---|
| 1 | 1 | 1 | |
| 1 | 2 | 2 | |
| 1 | 3 | 3 | |
| 2 | 1 | 2 | |
| 2 | 2 | 3 | |
| 2 | 3 | 1 | |
| 3 | 1 | 3 | |
| 3 | 2 | 1 | |
| 3 | 3 | 2 |
Orthogonal array L9 for VNS.
| L9 | A | B |
|---|---|---|
| 1 | 1 | |
| 1 | 2 | |
| 1 | 3 | |
| 2 | 1 | |
| 2 | 2 | |
| 2 | 3 | |
| 3 | 1 | |
| 3 | 2 | |
| 3 | 3 |
Fig. 8Mean S/N ratio plot for each level of the factors.
Fig. 9Mean RPD plot for each level of the factors.
Assessment metrics derived results for the effectiveness of each meta-heuristic.
| Example | NPS | MID | POD | MS |
|---|---|---|---|---|
| S1 | 4 3 | 2.34 3.56 | 21% 15% | 12,045 9765 |
| S2 | 3 2 | 2.56 3.78 | 23% 17% | 11,034 9653 |
| S3 | 5 3 | 3.02 3.89 | 27% 19% | 13,981 10,234 |
| S4 | 6 4 | 3.22 4.67 | 17% 15% | 10,342 9543 |
| S5 | 4 2 | 2.81 3.49 | 19% 16% | 9654 8765 |
| M1 | 7 5 | 4.23 5.65 | 15% 13% | 8761 6754 |
| M2 | 4 2 | 4.56 5.34 | 21% 19% | 11,298 10,451 |
| M3 | 8 6 | 3.72 4.92 | 28% 25% | 9213 8766 |
| M4 | 5 3 | 4.13 5.12 | 27% 20% | 12,098 10,221 |
| M5 | 7 6 | 5.18 6.22 | 20% 18% | 11,302 10,332 |
Fig. 10CPU time trend.
Fig. 11The means plot and LSD intervals for the suggested meta-heuristics.
Fig. 13The case study map in Tehran/Iran.
Fig. 12The derived non-dominant solutions' dispersion behavior by the proposed meta-heuristics in problem M1.
Vaccination centers related parameters.
| Center | V1 | V2 | V3 | V4 | V5 | V6 | V7 | V8 | V9 | V10 | V11 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 150,000 | 200,000 | 150,000 | 100,000 | 200,000 | 300,000 | 100,000 | 300,000 | 150,000 | 150,000 | 150,000 | |
| 200,000 | 200,000 | 300,000 | 150,000 | 400,000 | 200,000 | 130,000 | 180,000 | 250,000 | 200,000 | 350,000 | |
| 2 | 1 | 2 | 2 | 2 | 1 | 1 | 2 | 1 | 1.5 | 1 | |
| 1 | 2 | 2 | 2 | 1 | 1 | 2 | 1.5 | 2 | 1.5 | 2 | |
| 2000 | 3000 | 3000 | 4000 | 3000 | 2500 | 1000 | 4000 | 1500 | 4000 | 3000 | |
| 3000 | 1000 | 3500 | 2000 | 3000 | 1500 | 3000 | 5000 | 4000 | 3000 | 3000 | |
| 0.5 | 0.7 | 0.4 | 0.5 | 0.4 | 0.3 | 0.8 | 0.5 | 0.7 | 0.4 | 0.4 | |
| 0.5 | 0.5 | 0.6 | 0.5 | 0.7 | 0.3 | 0.5 | 0.7 | 0.6 | 0.6 | 0.7 |
Storage capacity of vaccines in hospitals.
| Vaccine | Barekat | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 6000 | 6000 | 5000 | 6000 | 4000 | 6000 | 5000 | 7000 | 5000 | 3500 | |
| 5000 | 4000 | 5500 | 4000 | 8000 | 4000 | 5000 | 7000 | 8000 | 6000 | |
| 4000 | 3000 | 3000 | 5000 | 7000 | 4000 | 5000 | 3000 | 7000 | 5000 | |
| 4000 | 5000 | 6000 | 7000 | 8000 | 7000 | 7000 | 5000 | 6000 | 8000 | |
Transportation cost of a dose of vaccine from manufacturers to hospitals in dollar.
| Transportation cost | H1 | H2 | H3 | H4 | H5 | H6 | H7 | H8 | H9 | H10 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 0.5 | 2 | 0.7 | 2 | 1 | 1 | 1 | 0.5 | 0.7 | |
| 1.5 | 2 | 0.5 | 0.8 | 2 | 1.5 | 0.7 | 1.1 | 0.8 | 2.5 | |
| 0.5 | 1.8 | 2 | 2.3 | 2.9 | 0.8 | 1 | 1.5 | 1.5 | 2.8 | |
| 3 | 1 | 1.1 | 0.3 | 0.3 | 1 | 0.4 | 0.5 | 0.7 | 0.7 | |
| 0.6 | 0.3 | 1 | 1.1 | 0.9 | 0.2 | 1 | 0.4 | 0.1 | 0.1 | |
| 0.4 | 0.5 | 1 | 0.5 | 1 | 0.8 | 0.5 | 0.4 | 0.6 | 0.9 | |
| Transportation cost | ||||||||||
| 1 | 0.5 | 1.5 | 0.8 | 1.5 | 1.2 | 1.2 | 1.1 | 0.6 | 0.8 | |
| 1.5 | 2 | 0.4 | 0.8 | 1.5 | 1.2 | 0.6 | 1.5 | 1 | 1 | |
| 1 | 2 | 2 | 2.3 | 2.5 | 0.8 | 0.8 | 1 | 2 | 2 | |
| 2.5 | 1 | 1.1 | 0.3 | 0.5 | 1 | 0.4 | 0.5 | 0.6 | 0.6 | |
| 0.6 | 0.5 | 1 | 1 | 0.9 | 0.5 | 0.8 | 0.4 | 0.1 | 0.5 | |
| 0.4 | 0.4 | 1.2 | 0.5 | 1 | 1 | 0.5 | 0.4 | 0.7 | 0.8 |
Simulation model parameters’ values.
| Parameters | Value | References |
|---|---|---|
| First COVID-19 case date reported | 13th March 2020 | Assumed |
| Susceptible population | 3000 | Assumed |
| Incubation time | 6 days | [ |
| Disease duration | 14 days | [ |
| Number of cases reported at the start | 42 | Assumed |
| Quarantine length | 15 days | [ |
| Fraction of the infected | 2% | [ |
| Average time to lose immunity | 5 days | [ |
| Number of available tests per day | 1000 per day | Assumed |
| Total students on campus | 8856 | Assumed |
| Average deaths rate | 3% | World Health Organization. (2021). |
| Transmission rate | 60 contacts/person | [ |
Fig. 14Distribution function of the estimated vaccine dose value.
Fig. 15Comparison of simulation results with real system.
Total amount of transferred vaccines from manufacturers to vaccination centers.
| Barekat | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Center | |||||||||
| 1580 | – | – | 2330 | 1240 | 810 | – | 2051 | – | |
| 540 | 2710 | 3125 | – | 1127 | – | – | – | – | |
| – | 3906 | 3892 | 1977 | – | 3843 | 2047 | – | – | |
| 2878 | 1616 | – | 3948 | – | – | – | 1324 | 2398 | |
| 1809 | – | – | 1490 | 2157 | 3154 | 1060 | 2644 | 2811 | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | 2932 | 960 | 3270 | 817 | 3145 | 1828 | |
| 2370 | – | 1410 | 814 | 518 | 3040 | – | – | ||
| – | 2242 | – | 3912 | 2379 | – | 3796 | 3554 | 3269 | |
| 2822 | 1093 | – | 1296 | – | 1125 | – | – | 1713 | |
| – | – | 3878 | – | 1228 | 1250 | 1658 | – | 834 | |
| 2692 | 3855 | – | 3422 | 2013 | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| 2242 | – | – | 3205 | – | 1873 | – | 3509 | 1204 | |
| Center | V1 | V2 | V3 | V5 | V6 | V7 | V9 | V10 | V11 |
| 3588 | 4682 | – | 4686 | 2471 | – | 2060 | – | – | |
| 1202 | 2336 | 2358 | 3830 | 3235 | 2103 | 3793 | 2850 | 1250 | |
| – | 4561 | 3154 | 823 | – | 877 | 801 | 4643 | – | |
| – | – | 2969 | – | 2458 | 3413 | – | – | – | |
| 1390 | 1513 | 1149 | 1278 | 1559 | 2666 | 822 | 3558 | 3719 | |
| – | 3393 | 1959 | 3747 | – | 1115 | – | 3603 | – | |
| – | – | – | – | – | – | – | – | – | |
| – | 3660 | – | 3708 | – | 1078 | 3972 | – | 1021 | |
| 2776 | – | 2718 | 3628 | 950 | 3343 | 3895 | 1155 | 2703 | |
| 3441 | 853 | – | 3756 | – | – | 3217 | – | – | |
| – | 3556 | – | 2335 | – | – | 3837 | – | – | |
| – | 3526 | 3793 | – | 2957 | – | 1672 | 1507 | – | |
| 3388 | – | 3931 | 840 | 3357 | – | 1196 | 3994 | – | |
| – | – | – | – | – | – | – | – | – | |
Vaccines inventory in hospitals.
| Sputnik | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Hospital | ||||||||||
| 1120 | 718 | 1516 | 550 | 2110 | 1325 | 1405 | 827 | 918 | 1678 | |
| 1008 | 649 | 2164 | 686 | 2410 | 556 | 728 | 1076 | 1100 | 887 | |
| Hospital | ||||||||||
| 516 | 1060 | 1970 | 1564 | 1410 | 2175 | 918 | 615 | 1884 | 716 | |
| Hospital | ||||||||||
| 2015 | 614 | 2466 | 1469 | 1762 | 819 | 2126 | 1736 | 910 | 1022 | |
Fig. 16Simulation model's sensitivity analysis.
Fig. 17Demand change behavior's effect on three objective functions.
Fig. 18The trend of demand changes' effect on vaccine shortage amount by dose.
| Index | |
| Set of the hospitals ( | |
| Set of the manufacturers ( | |
| Set of the vaccine age ( | |
| Set of the vaccination centers ( | |
| Types of the vaccines | |
| Set of the time periods | |
| Parameters | |
| A big number | |
| Vaccine | |
| Vaccine | |
| The priority cost of vaccines with age | |
| The priority cost of vaccines with age | |
| The cost of establishing vaccination center | |
| The cost of transporting a dose of vaccine from manufacturer | |
| The demolishing cost of perished vaccine | |
| The demolishing cost of perished vaccine | |
| The cost of purchasing and transporting a dose of vaccine | |
| The cost of purchasing and transporting a dose of vaccine | |
| The cost of producing a dose of vaccine | |
| The cost of holding a dose of vaccine | |
| The cost of holding a dose of vaccine | |
| The cost of holding a dose of vaccine | |
| The cost of setting up manufacturer | |
| The cost of overtime at vaccination center | |
| The cost of vaccine | |
| The cost of vaccine | |
| The cost of vaccine | |
| Number of vacant beds in hospital | |
| Number of vacant beds in vaccination center | |
| The initial number of reserved students in period | |
| The storage capacity of hospital | |
| The storage capacity of vaccination center | |
| The production capacity of manufacturer | |
| The amount of vaccine | |
| The amount of vaccine | |
| The desire of the students to receive money for vaccinations in period | |
| The level of the effectiveness of vaccination center | |
| Decision variables | |
| The shortage amount of vaccine | |
| The shortage amount of vaccine | |
| The shortage amount of vaccine | |
| Number of reserved students at the vaccination center | |
| Number of unreserved students at the vaccination center | |
| Number of reserved students at hospital | |
| Number of unreserved students at hospital | |
| The amount of vaccine | |
| The amount of vaccine | |
| The amount of vaccine | |
| The amount of vaccine | |
| The amount of vaccine | |
| The amount of vaccine | |
| 1 If vaccine | |
| 1 If hospital | |
| 1 If vaccination center | |
| 1 If unreserved students are referred to vaccination center | |
| 1 If unreserved students are referred to hospital | |
| 1 If vaccination center | |